Kinloch Capital LLC Makes New Investment in Cardinal Health, Inc. $CAH

Kinloch Capital LLC acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 21,389 shares of the company’s stock, valued at approximately $5,081,000. Cardinal Health makes up about 1.9% of Kinloch Capital LLC’s holdings, making the stock its 16th biggest position.

Several other institutional investors have also made changes to their positions in CAH. Royal Capital Wealth Management LLC purchased a new position in shares of Cardinal Health in the second quarter worth approximately $454,000. Legal & General Group Plc purchased a new stake in shares of Cardinal Health in the 2nd quarter valued at approximately $438,870,000. The Manufacturers Life Insurance Company acquired a new position in Cardinal Health in the 2nd quarter worth approximately $39,241,000. Fiduciary Financial Advisors acquired a new position in Cardinal Health in the 2nd quarter worth approximately $113,000. Finally, Manning & Napier Advisors LLC purchased a new position in Cardinal Health during the 2nd quarter worth approximately $29,873,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 1.1%

Cardinal Health stock opened at $232.13 on Tuesday. The company’s fifty day simple moving average is $232.13 and its 200-day simple moving average is $217.96. Cardinal Health, Inc. has a 12 month low of $145.87 and a 12 month high of $258.30. The stock has a market cap of $53.99 billion, a P/E ratio of 32.11, a P/E/G ratio of 1.23 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. Cardinal Health’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the business posted $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 12.54 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

Insider Activity at Cardinal Health

In related news, CEO Deborah Weitzman sold 7,354 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total value of $1,731,499.30. Following the transaction, the chief executive officer owned 77,901 shares in the company, valued at approximately $18,341,790.45. This represents a 8.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Jessica L. Mayer sold 29,436 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the completion of the sale, the insider owned 33,076 shares of the company’s stock, valued at $7,812,220.44. This trade represents a 47.09% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is currently owned by corporate insiders.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Analyst Ratings Changes

CAH has been the topic of several recent analyst reports. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Royal Bank Of Canada assumed coverage on Cardinal Health in a research report on Wednesday, August 19th. They set an “outperform” rating and a $276.00 price target on the stock. Wells Fargo & Company raised their price objective on Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Morgan Stanley lifted their target price on Cardinal Health from $255.00 to $265.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Finally, William Blair initiated coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $266.56.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.